Skip to Content

Vaccines, Volume 9, Issue 8

2021 August - 135 articles

Cover Story: The humoral and cellular immunogenicity of a candidate DNA vaccine expressing the subunit 1 (S1) of the spike protein from SARS-CoV-2 (pVAX-S1) was evaluated in BALB/c mice. Upon intramuscular administration using a needle-free system, three doses of 50 µg from pVAX-S1 elicited high titers of SARS-CoV-2 specific binding IgG and neutralizing antibodies. Analysis of IgG subclasses showed a Th1-polarized immune response as demonstrated by the significant elevation of S1-specific IgG2a and IgG2b compared to IgG1, which was further supported by the significantly high levels of polyfunctional S1- specific memory CD4+ and CD8+ T cells. These data suggest that pVAX-S1 is immunogenic and merits further preclinical and clinical testing. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles

There are no articles in this issue yet.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X